Lilly raises diabetes weight-loss bar with amylin-Zepbound combo - Fierce Biotech

1 sources1 storiesFirst seen 9/30/2026Score32Mixed Progress

Single Source

Bigness

Coverage

Recency

Engagement

Velocity

Confidence

Clipability

Polarization

Claims

Contradictions

Breakthrough

Sentiment Mix

Positive0%

Neutral100%

Negative0%

Geography

North America

Expert Signals

Politics - Google News US Headlines

source • 1 mention

AI-Generated Claims

Generated from linked receipts; click sources for full context.

Lilly raises diabetes weight-loss bar with amylin-Zepbound combo Fierce BiotechEli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial CNBCLilly's retatrutide GLP-1 delivers average weight loss of 50 pounds USA TodayPeople with Type 2 diabetes lost up to 60 pounds on Lilly's latest weight loss drug NBC News‘Godzilla' of weight-loss drugs could provide other important health benefits The Guardian

Supported by 1 story